294 related articles for article (PubMed ID: 28589744)
61. Moderate amounts of vitamin D3 in supplements are effective in raising serum 25-hydroxyvitamin D from low baseline levels in adults: a systematic review.
Whiting SJ; Bonjour JP; Payen FD; Rousseau B
Nutrients; 2015 Apr; 7(4):2311-23. PubMed ID: 25835074
[TBL] [Abstract][Full Text] [Related]
62. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis.
Guan SY; Cai HY; Wang P; Lv TT; Liu LN; Mao YM; Zhao CN; Wu Q; Dan YL; Sam NB; Wang DG; Pan HF
Int J Rheum Dis; 2019 Oct; 22(10):1803-1813. PubMed ID: 31468723
[TBL] [Abstract][Full Text] [Related]
63. Relationship between Serum 25-Hydroxyvitamin D Level and Risk of Recurrent Stroke.
Li G; Li L; Adachi JD; Wang R; Ye Z; Liu X; Thabane L; Lip GYH
Nutrients; 2022 May; 14(9):. PubMed ID: 35565874
[TBL] [Abstract][Full Text] [Related]
64. Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival.
Thanasitthichai S; Prasitthipayong A; Boonmark K; Purisa W; Guayraksa K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3101-3106. PubMed ID: 31653160
[TBL] [Abstract][Full Text] [Related]
65. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.
Weinstein SJ; Mondul AM; Yu K; Layne TM; Abnet CC; Freedman ND; Stolzenberg-Solomon RZ; Lim U; Gail MH; Albanes D
Eur J Epidemiol; 2018 Nov; 33(11):1087-1099. PubMed ID: 30073448
[TBL] [Abstract][Full Text] [Related]
66. A dose-response meta-analysis between serum concentration of 25-hydroxy vitamin D and risk of type 1 diabetes mellitus.
Hou Y; Song A; Jin Y; Xia Q; Song G; Xing X
Eur J Clin Nutr; 2021 Jul; 75(7):1010-1023. PubMed ID: 33235321
[TBL] [Abstract][Full Text] [Related]
67. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies.
Zhang R; Li B; Gao X; Tian R; Pan Y; Jiang Y; Gu H; Wang Y; Wang Y; Liu G
Am J Clin Nutr; 2017 Apr; 105(4):810-819. PubMed ID: 28251933
[No Abstract] [Full Text] [Related]
68. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis.
Hagenau T; Vest R; Gissel TN; Poulsen CS; Erlandsen M; Mosekilde L; Vestergaard P
Osteoporos Int; 2009 Jan; 20(1):133-40. PubMed ID: 18458986
[TBL] [Abstract][Full Text] [Related]
69. Associations of the risk of lung cancer with serum 25-hydroxyvitamin D level and dietary vitamin D intake: A dose-response PRISMA meta-analysis.
Wei H; Jing H; Wei Q; Wei G; Heng Z
Medicine (Baltimore); 2018 Sep; 97(37):e12282. PubMed ID: 30212966
[TBL] [Abstract][Full Text] [Related]
70. Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women.
Chandler PD; Tobias DK; Wang L; Smith-Warner SA; Chasman DI; Rose L; Giovannucci EL; Buring JE; Ridker PM; Cook NR; Manson JE; Sesso HD
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29315215
[TBL] [Abstract][Full Text] [Related]
71. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.
Goodwin PJ; Ennis M; Pritchard KI; Koo J; Hood N
J Clin Oncol; 2009 Aug; 27(23):3757-63. PubMed ID: 19451439
[TBL] [Abstract][Full Text] [Related]
72. Estimation of the dietary requirement for vitamin D in adolescents aged 14-18 y: a dose-response, double-blind, randomized placebo-controlled trial.
Smith TJ; Tripkovic L; Damsgaard CT; Mølgaard C; Ritz C; Wilson-Barnes SL; Dowling KG; Hennessy Á; Cashman KD; Kiely M; Lanham-New SA; Hart KH
Am J Clin Nutr; 2016 Nov; 104(5):1301-1309. PubMed ID: 27655438
[TBL] [Abstract][Full Text] [Related]
73. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
[TBL] [Abstract][Full Text] [Related]
74. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.
Gallagher JC; Sai A; Templin T; Smith L
Ann Intern Med; 2012 Mar; 156(6):425-37. PubMed ID: 22431675
[TBL] [Abstract][Full Text] [Related]
75. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.
Chen P; Li M; Gu X; Liu Y; Li X; Li C; Wang Y; Xie D; Wang F; Yu C; Li J; Chen X; Chu R; Zhu J; Ou Z; Wang H
PLoS One; 2013; 8(1):e49312. PubMed ID: 23382798
[TBL] [Abstract][Full Text] [Related]
76. Dietary calcium intake, vitamin D levels, and breast cancer risk: a dose-response analysis of observational studies.
Hong Z; Tian C; Zhang X
Breast Cancer Res Treat; 2012 Nov; 136(1):309-12. PubMed ID: 22872547
[TBL] [Abstract][Full Text] [Related]
77. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Freedman DM; Chang SC; Falk RT; Purdue MP; Huang WY; McCarty CA; Hollis BW; Graubard BI; Berg CD; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):889-94. PubMed ID: 18381472
[TBL] [Abstract][Full Text] [Related]
78. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants.
Kunutsor SK; Apekey TA; Steur M
Eur J Epidemiol; 2013 Mar; 28(3):205-21. PubMed ID: 23456138
[TBL] [Abstract][Full Text] [Related]
79. Correlates of 25-hydroxyvitamin D among Chinese breast cancer patients.
Shi L; Nechuta S; Gao YT; Zheng Y; Dorjgochoo T; Wu J; Cai Q; Zheng W; Lu W; Shu XO
PLoS One; 2014; 9(1):e86467. PubMed ID: 24466109
[TBL] [Abstract][Full Text] [Related]
80. Low serum vitamin D levels increase the mortality of cardiovascular disease in older adults: A dose-response meta-analysis of prospective studies.
Yang J; Ou-Yang J; Huang J
Medicine (Baltimore); 2019 Aug; 98(34):e16733. PubMed ID: 31441845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
